Old Web
English
Sign In
Acemap
>
authorDetail
>
Ahmadur Rahman
Ahmadur Rahman
Merck & Co.
Internal medicine
Medicine
Sorafenib
Pembrolizumab
previously treated
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study.
2021
Journal of Clinical Oncology
Philippe Merle
Julien Edeline
Mohamed Bouattour
Ann-Lii Cheng
Stephen L. Chan
Thomas Yau
Marcelo Garrido
Jennifer J. Knox
Bruno Daniele
Andrew X. Zhu
Valeriy Breder
Ho Yeong Lim
Sadahisa Ogasawara
Abby B. Siegel
Ahmadur Rahman
Ziwen Wei
Richard S. Finn
Show All
Source
Cite
Save
Citations (4)
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study.
2021
Journal of Clinical Oncology
Julien Edeline
Stéphane Cattan
Philippe Merle
Bruno Daniele
Stephen L. Chan
Thomas Yau
Mohamed Bouattour
Ho Yeong Lim
Yee Chao
Jennifer J. Knox
Sadahisa Ogasawara
Marcelo Garrido
Ann-Lii Cheng
Andrew X. Zhu
Richard S. Finn
Abby B. Siegel
Ahmadur Rahman
Chih-Chin Liu
Masatoshi Kudo
Show All
Source
Cite
Save
Citations (0)
1